Our website uses cookies to enable essential features and improve your browsing experience. Additionally, cookies enhance overall website functionality and user experience. By choosing I Accept, you agree to our use of non-essential cookies and other tracking technologies.

You have the ability to manage your settings or withdraw your consent at any time. We are committed to maintaining the privacy and security of your personal information. For detailed information on how we use cookies, including how to manage your privacy and preferences, please visit our cookie policy .
Developmentaid logo
Register
Print
Print
Horizon Europe (2021 - 2027)

Boosting the translation of biotech research into innovative health therapies

Last update: Jun 11, 2025 Last update: Jun 11, 2025

Details

Location:EU 27
EU 27
Funding agency:
Horizon Europe (2021 - 2027)
Contracting authority type:Development Institution
Status:Open
Budget: EUR 80,000,000
Award ceiling: EUR 8,000,000
Award floor: EUR 4,000,000
Sector:Health, Information & Communication Technology, Research
Languages:English
Eligible applicants:Unrestricted / Unspecified
Eligible citizenships:Afghanistan, Albania, Algeria, A ...
See more Afghanistan, Albania, Algeria, Angola, Argentina, Armenia, Aruba, Austria, Azerbaijan, Bangladesh, Belarus, Belgium, Belize, Benin, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Cape Verde, Central African Republic, Chad, Colombia, Comoros, Congo, Costa Rica, Cote d'Ivoire, Croatia, Cuba, Curaçao, Cyprus, Czech Republic, Dem. Rep. Congo, Denmark, Djibouti, Dominica, Commonwealth of, Dominican Republic, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Eswatini (Swaziland), Ethiopia, Faroe Islands, Fiji, Finland, France, French Polynesia, French Southern Territory, Gabon, Gambia, Georgia, Germany, Ghana, Greece, Greenland, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, Hungary, Iceland, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Jordan, Kazakhstan, Kenya, Kiribati, Kosovo, Kyrgyzstan, Laos, Latvia, Lebanon, Lesotho, Liberia, Libya, Lithuania, Luxembourg, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Mauritania, Mauritius, Micronesia, Moldova, Mongolia, Montenegro, Mozambique, Myanmar, Namibia, Nepal, Netherlands, New Caledonia, Nicaragua, Niger, Nigeria, North Korea, North Macedonia, Norway, Pakistan, Palestine / West Bank & Gaza, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Romania, Rwanda, Saint Lucia, Saint Martin, Saint Vincent and the Grenadines, Samoa, Sao Tome and Principe, Senegal, Serbia, Sierra Leone, Slovakia, Slovenia, Spain, St. Pierre and Miquelon, Sudan, Suriname, Sweden, Syria, Tajikistan, Tanzania, Thailand, Timor-Leste, Togo, Tonga, Tunisia, Turkey, Turkmenistan, Tuvalu, Uganda, Ukraine, Uzbekistan, Vanuatu, Venezuela, Vietnam, Wallis and Futuna, Yemen, Zambia, Zimbabwe
Date posted: May 15, 2025

Attachments • 8

Associated Awards

Quick summary

AI generated
Objectives: To accelerate the translation of biotech research into innovative health therapies, this grant supports the initial phases of clinical research, focusing on novel biotechnology-derived therapeutics. By fostering collaboration among SMEs, academics, clinicians, and research organizations, the grant aims to speed up clinical development, enhance competitiveness in the health biotech sector, and broaden access to advanced biotech therapies. The anticipated outcome includes increased clinical trials within the EU, improved global competitiveness for EU-based SMEs, and faster availability of innovative therapies for healthcare providers and patients.
Eligibility criteria: Eligibility is open to proposals featuring collaborative, multidisciplinary consortia comprising SMEs, academia, clinicians, and research organizations. SMEs must secure at least 50% of the EU contributi...

Description

Boosting the translation of biotech research into innovative health therapies TOPIC ID: HORIZON-HLTH-2025-01-TOOL-05 Type of grant: Call for proposals General information Programme: Call: Cluster 1 - Health (Single stage - 2025) (HORIZON-HLTH-2025-01) Typ
Want to unlock full information?
Member-only information. Become a member to access this information. Procurement notices from over 112+ donors and banks are available here
Learn more about our membership benefits
Print
Similar grants
By Locations
Draper Richards Kaplan Foundat
Draper Richards Kaplan Foundation Grants for Entrepreneurs and NGOs
Draper Richards Kaplan Foundation Grants for Entrepreneurs and NGOs
Funding agency:
NPO
Status:
open
Location:
Africa, EU 27, Europe Non EU 27, Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, French Guiana, Guatemala, Guyana, Honduras, India, Mexico, Nicaragua, Panama, Paraguay, Peru, Suriname, Uruguay, USA, Venezuela
CFAs: Development of Minority
CFAs: Development of Minority Co-Production Scheme
CFAs: Development of Minority Co-Production Scheme
Funding agency:
NPO
Status:
open
Location:
EU 27, Iceland, Liechtenstein, Norway, Switzerland
View 1174 more
By Sectors
Request for Disaster Resilienc
Request for Disaster Resilience, Response, and Recovery Projects - Austria
Request for Disaster Resilience, Response, and Recovery Projects - Austria
Funding agency:
Government
Status:
open
Location:
Austria
Call for Projects: Globalstars
Call for Projects: Globalstars Funding Programme 2025 - Poland
Call for Projects: Globalstars Funding Programme 2025 - Poland
Funding agency:
Government
Status:
open
Location:
Poland
View 25 more